Graham K. Cooper

Insider Reports History

Entity
Individual
Location
C/O Receptos, Inc., 10835 Road To The Cure, Suite 205, San Diego, CA
Signature
/s/ Marc Belsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Graham K. Cooper:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 23.1K $564K $24.40 Jun 5, 2024 Direct
Applied Molecular Transport Inc. Director Stock Option (Right to Buy) 300K Jan 27, 2022 Direct
Kezar Life Sciences, Inc. Director Stock Option (right to buy) 50K Jun 20, 2024 Direct
Unity Biotechnology, Inc. Director Stock Option (Right to Buy) 25K Jun 24, 2021 Direct

Insider Reports Filed by Graham K. Cooper

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KZR Kezar Life Sciences, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
BEAM Beam Therapeutics Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
KZR Kezar Life Sciences, Inc. Jul 24, 2023 10 $0 4 Jul 26, 2023 Director
KZR Kezar Life Sciences, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
BEAM Beam Therapeutics Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
BEAM Beam Therapeutics Inc. Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
KZR Kezar Life Sciences, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
KZR Kezar Life Sciences, Inc. May 12, 2022 1 $0 4 May 13, 2022 Director
AMTI Applied Molecular Transport Inc. Jan 27, 2022 1 $0 4 Jan 31, 2022 Director
BEAM Beam Therapeutics Inc. Jul 6, 2021 14 -$271K 4 Jul 8, 2021 Director
KZR Kezar Life Sciences, Inc. Jun 28, 2021 1 $0 4 Jun 30, 2021 Director
BEAM Beam Therapeutics Inc. Jun 28, 2021 7 -$1.08M 4 Jun 30, 2021 Director
UBX Unity Biotechnology, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
BEAM Beam Therapeutics Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
AMTI Applied Molecular Transport Inc. May 18, 2021 1 $0 4 May 20, 2021 Director